Effect of donepezil on the continuum of depressive symptoms, mild cognitive impairment, and progression to dementia

Journal of the American Geriatrics Society

Volumn 58, Issue 2, 2010, Pages 389-390

  Panza, Francesco ^a   Frisardi, Vincenza ^b   Capurso, Cristiano ^a   D'Introno, Alessia ^a   Colacicco, Anna M ^a   Chiloiro, Roberta ^a   Dellegrazie, Flora ^a   Di Palo, Alessandra ^a   Capurso, Antonio ^a   Solfrizzi, Vincenzo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; PLACEBO; RIVASTIGMINE;

DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; FOLLOW UP; HUMAN; INCIDENCE; LETTER; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; DEPRESSIVE DISORDER; DISEASE PROGRESSION; HUMANS; INDANS; NOOTROPIC AGENTS; PIPERIDINES;

EID: 75749087996     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2009.02702.x     Document Type: Letter

References (10)

1. Panza F, Solfrizzi V, Frisardi V et al. Disease-modifying approach to the treatment of Alzheimer's disease: From alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging 2009 26 : 537 555.
2. Raschetti R, Albanese E, Vanacore N et al. Cholinesterase inhibitors in mild cognitive impairment: A systematic review of randomised trials. PLoS Med 2007 4 : e338.
3. Lu PH, Edland SD, Teng E et al. on behalf of the Alzheimer's Disease Cooperative Study Group. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology 2009 72 : 2115 2121.
4. Panza F, D'Introno A, Colacicco AM et al. Late-life depression, mild cognitive impairment, and dementia: A possible continuum? Am J Geriatr Psychiatry DOI :.
5. Solfrizzi V, D'Introno A Italian Longitudinal Study on Aging Working Group. et al. Incident occurrence of depressive symptoms among patients with mild cognitive impairment. The Italian Longitudinal Study on Aging. Dement Geriatr Cogn Disord 2007 24 : 55 64. (Pubitemid 46985292)
6. Panza F, Capurso C, D'Introno A et al., for the Italian Longitudinal Study on Aging Working Group. Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging. Int J Geriatr Psychiatry 2008 23 : 726 734.
7. Panza F, D'Introno A, Colacicco AM et al., for the Italian Longitudinal Study on Aging Working Group. Depressive symptoms, vascular risk factors, and mild cognitive impairment. The Italian Longitudinal Study on Aging. Dement Geriatr Cogn Disord 2008 25 : 336 346.
8. Petersen RC, Thomas RG, Grundman M et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005 352 : 2379 2388.
9. Butters MA, Young JB, Lopez O et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci 2008 10 : 345 357.
10. Panza F, D'Introno A, Colacicco AM et al. Temporal relationship between depressive symptoms and cognitive impairment: The Italian Longitudinal Study on Aging. J Alzheimers Dis 2009 Jun 19. [Epub ahead of print].